Acu/moxa for distal sensory peripheral neuropathy in hiv: A randomized control pilot study

Journal of the Association of Nurses in AIDS Care

Volumn 24, Issue 3, 2013, Pages 268-275

  Anastasi, Joyce K ^a   Capili, Bernadette ^a   McMahon, Donald J ^b   Scully, Colin ^a  

^a NEW YORK UNIVERSITY   (United States)

^b Division of Endocrinology ^*  (United States)

Author keywords

Acupuncture; Clinical trial; HIV; Moxibustion; Peripheral neuropathy; Research

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEG; MALE; MIDDLE AGED; MOXIBUSTION; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HIV INFECTIONS; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; MOXIBUSTION; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; TREATMENT OUTCOME;

EID: 84876335599     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2012.09.006     Document Type: Article

References (30)

1. Anastasi J., Capili B., Chung A., Hammerschlag R. Acupuncture/moxibustion RCT for distal sensory peripheral neuropathy in HIV/AIDS: Rationale, design, methods, procedures and logistics. European Journal of Oriental Medicine 2010, 6(4):40-52.
2. Ances B., Ellis R. Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology 2007, 27(1):86-92.
3. Beijing College of Traditional Chinese Medicine Chinese acupuncture and moxibustion 1987, Foreign Languages Press, Beijing, China.
4. Birch S., Hammerschlag R., Trinh K., Zaslawski C. The non-specific effects of acupuncture treatment: When and how to control for them. Clinical Acupuncture and Oriental Medicine 2002, 3(1):20-25.
5. Borkovec T.D., Nau S.D. Credibility of analogue therapy rationales. Journal of Behavioral Therapy & Experimental Pyschiatry 1972, 3(4):257-260. 10.1016/0005-7916(72)90045-6.
6. Centers for Disease Control and Prevention. (1993). Statement concerning clinical trial of acupuncture and amitriptyline for pain relief. Retrieved from http://ww1.aegis.org/pubs/Cdc_Fact_Sheets/1993/CDC93154.html.
7. Cornblath D., Hoke A. Recent advances in HIV neuropathy. Current Opinion in Neurology 2006, 19(5):446-450. 10.1097/01.wco.0000245366.59446.57.
8. Dworkin R., O'Connor A., Audette J., Baron R., Gourlay G., Haanpää M., Wells C., et al. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clinic Proceedings 2010, 85(Suppl. 3):S3-S14. 10.4065/mcp.2009.0649.
9. Ellis R., Rosario D., Clifford D., McArthur J., Simpson D., Alexander T., Grant I., et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy. Archives in Neurology 2010, 67(5):552-558. 10.1001/archneurol.2010.76.
10. Evans S., Ellis R., Chen H., Yeh T., Lee A., Schifitto G., Clifford D., et al. Peripheral neuropathy in HIV: Prevalence and risk factors. AIDS 2011, 25(7):919-928. 10.1097/QAD.0b013e328345889d.
11. Fairfield K., Eisenberg D., Davis R., Libman H., Phillips R. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Archives of Internal Medicine 1998, 158:2257-2264.
12. Ferrari S., Vento S., Monaco S., Cavallaro T., Cainelli F., Rizzuto N., Temesgen Z. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clinic Proceedings 2006, 81(2):213-219.
13. Gonzalez-Duarte A., Cikurel K., Simpson D.M. Managing HIV peripheral neuropathy. Current HIV/AIDS Reports 2007, 4(3):114-118. 10.1007/s11904-007-0017-6.
14. Gore-Felton C., Vosvick M., Power R., Koopman C., Ashton E., Bachmann M.H., Spiegel D., et al. Alternative therapies: A common practice among men and women living with HIV. Journal of the Association of Nurses in AIDS Care 2003, 14(3):17-27. 10.1177/1055329003014003002.
15. Hammerschlag, R. (1997). Methodological and ethical issues in acupuncture research. In the NIH consensus development conference on acupuncture (pp. 45-49). Retrieved from http://consensus.nih.gov/1997/1997acupuncture107program.pdf.
16. Keswani S., Pardoa C.A., Cherry C.L., Hokea A., McArthur J.C. HIV-associated sensory neuropathies. AIDS 2002, 16(16):2105-2117.
17. Liangyue D., Yijun G., Shuhui J. Chinese acupuncture and moxibustion 1993, Foreign Languages Press, Beijing, China.
18. Littlewood R.A., Vanable P.A. Complementary and alternative medicine use among HIV+ people: Research synthesis and implications for HIV care. AIDS Care 2008, 20(8):1002-1018. 10.1080/09540120701767216.
19. McArthur J. The reliability and validity of the subjective peripheral neuropathy screen. Journal of the Association of Nurses in AIDS Care 1998, 9(4):84-94. 10.1016/S1055-3290(98)80048-4.
20. McArthur J., Yiannoutsos C., Simpson D.M., Adornato B.T., Singer E.J., Hollander H., Clifford D.B., et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology 2000, 54(5):1080-1088. 10.1212/WNL.54.5.1080.
21. McArthur J.C., Brew B.J., Nath A. Neurological complications of HIV infection. Lancet Neurology 2005, 4(9):543-555. 10.1016/S1474-4422(05)70165-4.
22. Nicholas P., Kemppainen J., Canaval G., Corless I., Sefcik E., Nokes K., Gallagher D., et al. Symptom management and self-care for peripheral neuropathy in HIV/AIDS. AIDS Care 2007, 19(2):179-189. 10.1080/09540120600971083.
23. Nicholas P., Kemppainen J., Holzmer W., Nokes K., Sanzero E., Corless I., Goodroad B., et al. Self-care management for neuropathy in HIV disease. AIDS Care 2002, 14(6):763-771. 10.1080/0954012021000031831.
24. Nicholas P., Voss J., Wantland D., Lindgren T., Huang E., Holzemer W., Bain C., et al. Prevalence, self-care behaviors, and self-care activities for peripheral neuropathy symptoms of HIV/AIDS. Nursing and Health Sciences 2010, 12(1):119-126. 10.1111/j.1442-2018.2009.00505.x.
25. Schifitto G., McDermott M.P., McArthur J.C., Marder K., Sacktor N., Epstein L., Kieburtz K. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002, 58(12):1764-1768. 10.1212/WNL.58.12.1764.
26. Silver M., Blum D., Grainger J., Hammer A.E., Quessy S. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management 2007, 34(4):446-454. 10.1016/j.jpainsymman.2006.12.015.
27. Simpson D., Estanislao L., Brown S.L., Sampson J. An open-label pilot study of high concentration capsaicin patch in painful HIV neuropathy. Journal of Pain Symptom Mangement 2008, 35(3):299-306. 10.1016/j.jpainsymman.2007.04.015.
28. Simpson D., Schifitto G., Clifford D., Murphy T., Durso-De Cruz E., Glue P., Freeman R., et al. Pregabalin for painful HIV neuropathy. Neurology 2010, 74(5):413-420. 10.1212/WNL.0b013e318.
29. Verma S., Estanislao L., Simpson D.M. HIV-associated neuropathic pain: Epidemiology, pathophysiology and management. CNS Drugs 2005, 19(4):325-334.
30. Vincent C., Lewith G. Placebo controls for acupuncture studies. Journal of the Royal Society of Medicine 1995, 88(4):199-202.